Zaroxolyn | Metolazone 12 [hp_x] Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Zaroxolyn | Metolazone 12 [hp_x] while breastfeeding. We will also discuss about common side effects and warnings associated with Zaroxolyn | Metolazone 12 [hp_x].

What is Zaroxolyn | Metolazone 12 [hp_x] used for?


ZAROXOLYN is indicated for the treatment of salt and water retention including: edema accompanying congestive heart failure; edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function. ZAROXOLYN is also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. MYKROX Tablets, a more rapidly available form of metolazone, are intended for the treatment of new patients with mild to moderate hypertension. A dose titration is necessary if MYKROX Tablets are to be substituted for ZAROXOLYN in the treatment of hypertension. See package circular for MYKROX Tablets (UCB). Usage In Pregnancy The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy, and there is no evidence that they are useful in the treatment of developed toxemia. Edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. ZAROXOLYN is indicated in pregnancy when edema is due to pathologic causes, just as it is in the absence of pregnancy (see PRECAUTIONS). Dependent edema in pregnancy resulting from restriction of venous return by the expanded uterus is properly treated through elevation of the lower extremities and use of support hose; use of diuretics to lower intravascular volume in this case is illogical and unnecessary. There is hypervolemia during normal pregnancy which is harmful to neither the fetus nor the mother (in the absence of cardiovascular disease), but which is associated with edema, including generalized edema, in the majority of pregnant women. If this edema produces discomfort, increased recumbency will often provide relief. In rare instances, this edema may cause extreme discomfort which is not relieved by rest. In these cases, a short course of diuretics may be appropriate.

Zaroxolyn | Metolazone 12 [hp_x] while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?

Zaroxolyn | Metolazone 12 [hp_x] contains Metolazone as active ingredients, . We do not have safety rating of Metolazone but we do have analysis of Metolazone, which is used in manufacturing of Zaroxolyn | Metolazone 12 [hp_x]. You can get a good idea about Zaroxolyn | Metolazone 12 [hp_x] usage while breastfeeding by going through our detailed analysis as below.

Statement of Manufacturer/Labeler about breastfeeding usage
Nursing Mothers Metolazone appears in breast milk. Because of the potential for serious adverse reactions in nursing infants from metolazone, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Zaroxolyn | Metolazone 12 [hp_x] Breastfeeding Analsys


Metolazone while Breastfeeding

CAS Number: 17560-51-9

If metolazone is required by the mother, it is not a reason to discontinue breastfeeding. Intense diuresis with large doses may decrease breastmilk production.


Is Zaroxolyn | Metolazone 12 [hp_x] safe while breastfeeding

What should I do if already breastfed my kid after using Zaroxolyn | Metolazone 12 [hp_x]?

We are not completely sure about safety of Zaroxolyn | Metolazone 12 [hp_x] in breastfeeding. We would suggest you to contact your doctor or health care provider and explain your situation with Zaroxolyn | Metolazone 12 [hp_x]. If you observe anything abnormal with your baby please call 911 or contact emergency services in your area.


I am nursing mother and my doctor has suggested me to use Zaroxolyn | Metolazone 12 [hp_x], is it safe?

If your doctor considers Zaroxolyn | Metolazone 12 [hp_x] safe enough to prescribe for you that means its benefits outweigh its known risks.


If I am using Zaroxolyn | Metolazone 12 [hp_x], will my baby need extra monitoring?

Not Sure, Please check with your doctor or lactation consultant.


Who can I talk to if I have questions about usage of Zaroxolyn | Metolazone 12 [hp_x] in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week